Arrested Development: Slow Progression of Fibrosis in Patients with NAFLD and IBD

Affiliations

¹ Vatche and Tamar Manoukian Division of Digestive Diseases, UCLA School of Medicine, 100 UCLA Medical Plaza Suite #345, Los Angeles, CA, 90095, USA.
² Vatche and Tamar Manoukian Division of Digestive Diseases, UCLA School of Medicine, 100 UCLA Medical Plaza Suite #345, Los Angeles, CA, 90095, USA. berkeley.limketkai@gmail.com.

Editorial

Yejoo Jeon et al. Dig Dis Sci. 2021 Sep.

. 2021 Sep;66(9):2853-2854.

doi: 10.1007/s10620-020-06672-x. Epub 2020 Oct 22.

¹ Vatche and Tamar Manoukian Division of Digestive Diseases, UCLA School of Medicine, 100 UCLA Medical Plaza Suite #345, Los Angeles, CA, 90095, USA.
² Vatche and Tamar Manoukian Division of Digestive Diseases, UCLA School of Medicine, 100 UCLA Medical Plaza Suite #345, Los Angeles, CA, 90095, USA. berkeley.limketkai@gmail.com.

No abstract available

Comment on

Nonalcoholic Fatty Liver Disease Is Common in IBD Patients However Progression to Hepatic Fibrosis by Noninvasive Markers Is Rare.
Ritaccio G, Stoleru G, Abutaleb A, Cross RK, Shetty K, Sakiani S, Wong U. Ritaccio G, et al. Dig Dis Sci. 2021 Sep;66(9):3186-3191. doi: 10.1007/s10620-020-06588-6. Epub 2020 Sep 7. Dig Dis Sci. 2021. PMID: 32894439 Free PMC article.

1. Sanyal AJ. Past, present and future perspectives in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2019;16:377–386. https://doi.org/10.1038/s41575-019-0144-8 . - DOI - PubMed
1. Zou ZY, Shen B, Fan JG. Systematic review with meta-analysis: epidemiology of nonalcoholic fatty liver disease in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2019;25:1764–1772. https://doi.org/10.1093/ibd/izz043 . - DOI - PubMed
1. Angulo P, Kleiner DE, Dam-Larsen S, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015;149:389–97.e10. https://doi.org/10.1053/j.gastro.2015.04.043 . - DOI
1. Dulai PS, Singh S, Patel J, et al. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis. Hepatology. 2017;65:1557–1565. https://doi.org/10.1002/hep.29085 . - DOI
1. Ekstedt M, Nasr P, Kechagias S. Natural history of NAFLD/NASH. Curr Hepatol Rep. 2017;16:391–397. https://doi.org/10.1007/s11901-017-0378-2 . - DOI - PubMed - PMC